Felic Fanusi

Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety

Wei Zheng. Lim, J. Chu, O. Liew, 2022, ACS omega.

A blood RNA transcriptome signature for COVID-19

M. Hibberd, O. Sessions, N. Paton, 2021, BMC medical genomics.

Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.

C. Kityo, N. Paton, K. Chew, 2023, The Lancet. Infectious diseases.